Author:
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 232
Book Description
U.S. Government Research & Development Reports
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1040
Book Description
Includes subject section, name section, and 1968-1970, technical reports.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1040
Book Description
Includes subject section, name section, and 1968-1970, technical reports.
Research and Development in the Pharmaceutical Industry (A CBO Study)
Author: Congressional Budget Office
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
U.S. Government Research Reports
Indexed Bibliography of Office of Research and Development Reports
Author: United States. Environmental Protection Agency. Office of Program Management
Publisher:
ISBN:
Category : Environmental protection
Languages : en
Pages : 286
Book Description
Publisher:
ISBN:
Category : Environmental protection
Languages : en
Pages : 286
Book Description
National Library of Medicine Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages :
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages :
Book Description
First multi-year cumulation covers six years: 1965-70.
Research in Education
Health Research
Author: Commission on Health Research for Development
Publisher: Oxford University Press, USA
ISBN: 9780195208382
Category : Medical
Languages : en
Pages : 170
Book Description
Health and development. Funding research. Research priorities in developing countries, in industrialized countries and international centers. International research promotion. An agenda for action. Summary of specific-recommendations
Publisher: Oxford University Press, USA
ISBN: 9780195208382
Category : Medical
Languages : en
Pages : 170
Book Description
Health and development. Funding research. Research priorities in developing countries, in industrialized countries and international centers. International research promotion. An agenda for action. Summary of specific-recommendations
The Measurement of Scientific, Technological and Innovation Activities Frascati Manual 2015 Guidelines for Collecting and Reporting Data on Research and Experimental Development
Author: OECD
Publisher: OECD Publishing
ISBN: 9264239014
Category :
Languages : en
Pages : 402
Book Description
The internationally recognised methodology for collecting and using R&D statistics, the OECD's Frascati Manual is an essential tool for statisticians and science and innovation policy makers worldwide. It includes definitions of basic concepts, data collection guidelines, and classifications ...
Publisher: OECD Publishing
ISBN: 9264239014
Category :
Languages : en
Pages : 402
Book Description
The internationally recognised methodology for collecting and using R&D statistics, the OECD's Frascati Manual is an essential tool for statisticians and science and innovation policy makers worldwide. It includes definitions of basic concepts, data collection guidelines, and classifications ...
Heavily Indebted Poor Countries (HIPC) Initiative and Multilateral Debt Relief Initiative (MDRI) - Status of Implementation
Author: World Bank
Publisher: International Monetary Fund
ISBN: 1498333281
Category : Business & Economics
Languages : en
Pages : 106
Book Description
This report provides an update on the status of implementation, impact and costs of the enhanced Heavily Indebted Poor Country (HIPC) Initiative and the Multilateral Debt Relief Initiative (MDRI) since mid-2006. It also discusses the status of creditor participation in both initiatives and the issue of litigation of commercial creditors against HIPCs.
Publisher: International Monetary Fund
ISBN: 1498333281
Category : Business & Economics
Languages : en
Pages : 106
Book Description
This report provides an update on the status of implementation, impact and costs of the enhanced Heavily Indebted Poor Country (HIPC) Initiative and the Multilateral Debt Relief Initiative (MDRI) since mid-2006. It also discusses the status of creditor participation in both initiatives and the issue of litigation of commercial creditors against HIPCs.